Annual CAPEX
$6000.00
-$1000.00-14.29%
December 31, 2023
Summary
- As of February 7, 2025, CYCC annual capital expenditures is $6000.00, with the most recent change of -$1000.00 (-14.29%) on December 31, 2023.
- During the last 3 years, CYCC annual CAPEX has fallen by -$90.00 thousand (-93.75%).
- CYCC annual CAPEX is now -99.87% below its all-time high of $4.45 million, reached on December 31, 2004.
Performance
CYCC CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
N/A
September 30, 2024
Summary
- CYCC quarterly capital expenditures is not available.
Performance
CYCC Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CAPEX
N/A
September 30, 2024
Summary
- CYCC TTM capital expenditures is not available.
Performance
CYCC TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
CYCC CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.3% | - | - |
| 3 y3 years | -93.8% | - | - |
| 5 y5 years | -84.6% | - | - |
CYCC CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -77.8% | at low | ||||
| 5 y | 5-year | -93.8% | at low | ||||
| alltime | all time | -99.9% | +100.0% |
Cyclacel Pharmaceuticals CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $6000.00(-14.3%) | $0.00(0.0%) | $6000.00(0.0%) |
| Sep 2023 | - | $0.00(0.0%) | $6000.00(0.0%) |
| Jun 2023 | - | $0.00(-100.0%) | $6000.00(-33.3%) |
| Mar 2023 | - | $6000.00(>+9900.0%) | $9000.00(+28.6%) |
| Dec 2022 | $7000.00(-74.1%) | $0.00(0.0%) | $7000.00(-22.2%) |
| Sep 2022 | - | $0.00(-100.0%) | $9000.00(-50.0%) |
| Jun 2022 | - | $3000.00(-25.0%) | $18.00 K(-138.3%) |
| Mar 2022 | - | $4000.00(+100.0%) | -$47.00 K(-274.1%) |
| Dec 2021 | $27.00 K(-71.9%) | $2000.00(-77.8%) | $27.00 K(-59.7%) |
| Sep 2021 | - | $9000.00(-114.5%) | $67.00 K(-38.0%) |
| Jun 2021 | - | -$62.00 K(-179.5%) | $108.00 K(-36.5%) |
| Mar 2021 | - | $78.00 K(+85.7%) | $170.00 K(+77.1%) |
| Dec 2020 | $96.00 K(+860.0%) | $42.00 K(-16.0%) | $96.00 K(+68.4%) |
| Sep 2020 | - | $50.00 K(>+9900.0%) | $57.00 K(+418.2%) |
| Jun 2020 | - | $0.00(-100.0%) | $11.00 K(-8.3%) |
| Mar 2020 | - | $4000.00(+33.3%) | $12.00 K(+20.0%) |
| Dec 2019 | $10.00 K(-74.4%) | $3000.00(-25.0%) | $10.00 K(-23.1%) |
| Sep 2019 | - | $4000.00(+300.0%) | $13.00 K(+18.2%) |
| Jun 2019 | - | $1000.00(-50.0%) | $11.00 K(-42.1%) |
| Mar 2019 | - | $2000.00(-66.7%) | $19.00 K(-51.3%) |
| Dec 2018 | $39.00 K(+200.0%) | $6000.00(+200.0%) | $39.00 K(+11.4%) |
| Sep 2018 | - | $2000.00(-77.8%) | $35.00 K(-16.7%) |
| Jun 2018 | - | $9000.00(-59.1%) | $42.00 K(+27.3%) |
| Mar 2018 | - | $22.00 K(+1000.0%) | $33.00 K(+153.8%) |
| Dec 2017 | $13.00 K(+333.3%) | $2000.00(-77.8%) | $13.00 K(+18.2%) |
| Sep 2017 | - | $9000.00(>+9900.0%) | $11.00 K(+450.0%) |
| Jun 2017 | - | $0.00(-100.0%) | $2000.00(0.0%) |
| Mar 2017 | - | $2000.00(0.0%) | $2000.00(-94.1%) |
| Dec 2016 | $3000.00(-91.2%) | - | - |
| Dec 2015 | $34.00 K(-89.0%) | $2000.00(-80.0%) | $34.00 K(-12.8%) |
| Sep 2015 | - | $10.00 K(+25.0%) | $39.00 K(-85.3%) |
| Jun 2015 | - | $8000.00(-42.9%) | $266.00 K(-8.9%) |
| Mar 2015 | - | $14.00 K(+100.0%) | $292.00 K(-5.5%) |
| Dec 2014 | $309.00 K(+48.6%) | $7000.00(-97.0%) | $309.00 K(-24.8%) |
| Sep 2014 | - | $237.00 K(+597.1%) | $411.00 K(+127.1%) |
| Jun 2014 | - | $34.00 K(+9.7%) | $181.00 K(+23.1%) |
| Mar 2014 | - | $31.00 K(-71.6%) | $147.00 K(-29.3%) |
| Dec 2013 | $208.00 K | $109.00 K(+1457.1%) | $208.00 K(+110.1%) |
| Sep 2013 | - | $7000.00(>+9900.0%) | $99.00 K(+5.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2013 | - | $0.00(-100.0%) | $94.00 K(-1.1%) |
| Mar 2013 | - | $92.00 K(>+9900.0%) | $95.00 K(+691.7%) |
| Dec 2012 | $12.00 K(+100.0%) | $0.00(-100.0%) | $12.00 K(0.0%) |
| Sep 2012 | - | $2000.00(+100.0%) | $12.00 K(-25.0%) |
| Jun 2012 | - | $1000.00(-88.9%) | $16.00 K(+6.7%) |
| Mar 2012 | - | $9000.00(>+9900.0%) | $15.00 K(+150.0%) |
| Dec 2011 | $6000.00(-25.0%) | $0.00(-100.0%) | $6000.00(0.0%) |
| Sep 2011 | - | $6000.00(>+9900.0%) | $6000.00(-25.0%) |
| Dec 2010 | $8000.00(-46.7%) | $0.00(0.0%) | $8000.00(-20.0%) |
| Sep 2010 | - | $0.00(-100.0%) | $10.00 K(-23.1%) |
| Jun 2010 | - | $3000.00(-40.0%) | $13.00 K(-27.8%) |
| Mar 2010 | - | $5000.00(+150.0%) | $18.00 K(+20.0%) |
| Dec 2009 | $15.00 K(-95.9%) | $2000.00(-33.3%) | $15.00 K(-40.0%) |
| Sep 2009 | - | $3000.00(-62.5%) | $25.00 K(-53.7%) |
| Jun 2009 | - | $8000.00(+300.0%) | $54.00 K(-65.8%) |
| Mar 2009 | - | $2000.00(-83.3%) | $158.00 K(-56.8%) |
| Dec 2008 | $366.00 K(-79.4%) | $12.00 K(-62.5%) | $366.00 K(-72.4%) |
| Sep 2008 | - | $32.00 K(-71.4%) | $1.33 M(-9.9%) |
| Jun 2008 | - | $112.00 K(-46.7%) | $1.47 M(-20.0%) |
| Mar 2008 | - | $210.00 K(-78.4%) | $1.84 M(+3.8%) |
| Dec 2007 | $1.77 M(+165.8%) | $973.00 K(+446.6%) | $1.77 M(+32.9%) |
| Sep 2007 | - | $178.00 K(-62.9%) | $1.33 M(+9.4%) |
| Jun 2007 | - | $480.00 K(+238.0%) | $1.22 M(+59.8%) |
| Mar 2007 | - | $142.00 K(-73.4%) | $763.00 K(+14.4%) |
| Dec 2006 | $667.00 K(+153.6%) | $534.00 K(+747.6%) | $667.00 K(+105.9%) |
| Sep 2006 | - | $63.00 K(+162.5%) | $324.00 K(+8.7%) |
| Jun 2006 | - | $24.00 K(-47.8%) | $298.00 K(+2.4%) |
| Mar 2006 | - | $46.00 K(-75.9%) | $291.00 K(+10.6%) |
| Dec 2005 | $263.00 K(-94.1%) | $191.00 K(+416.2%) | $263.00 K(-69.5%) |
| Sep 2005 | - | $37.00 K(+117.6%) | $861.00 K(-70.2%) |
| Jun 2005 | - | $17.00 K(-5.6%) | $2.89 M(-29.4%) |
| Mar 2005 | - | $18.00 K(-97.7%) | $4.09 M(-8.0%) |
| Dec 2004 | $4.45 M(+346.9%) | $789.00 K(-61.8%) | $4.45 M(+5.5%) |
| Sep 2004 | - | $2.06 M(+69.4%) | $4.22 M(+83.3%) |
| Jun 2004 | - | $1.22 M(+225.9%) | $2.30 M(+102.4%) |
| Mar 2004 | - | $374.00 K(-33.1%) | $1.14 M(+14.3%) |
| Dec 2003 | $995.00 K | $559.00 K(+275.2%) | $995.00 K(+128.2%) |
| Sep 2003 | - | $149.00 K(+170.9%) | $436.00 K(+51.9%) |
| Jun 2003 | - | $55.00 K(-76.3%) | $287.00 K(+23.7%) |
| Mar 2003 | - | $232.00 K | $232.00 K |
FAQ
- What is Cyclacel Pharmaceuticals annual capital expenditures?
- What is the all time high annual CAPEX for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals annual CAPEX year-on-year change?
- What is the all time high quarterly CAPEX for Cyclacel Pharmaceuticals?
- What is the all time high TTM CAPEX for Cyclacel Pharmaceuticals?
What is Cyclacel Pharmaceuticals annual capital expenditures?
The current annual CAPEX of CYCC is $6000.00
What is the all time high annual CAPEX for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high annual capital expenditures is $4.45 M
What is Cyclacel Pharmaceuticals annual CAPEX year-on-year change?
Over the past year, CYCC annual capital expenditures has changed by -$1000.00 (-14.29%)
What is the all time high quarterly CAPEX for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high quarterly capital expenditures is $2.06 M
What is the all time high TTM CAPEX for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high TTM capital expenditures is $4.45 M